RBA Wealth Management’s DexCom DXCM Stock Holding History

RBA Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-128	Closed	-$11.5K	–	99
2021 Q1	$11.5K	Buy	+128	New	+$12K	0.01%	141

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RBA Wealth Management's DXCM Position: Q2 2021 in Review

RBA Wealth Management sold out of DexCom (DXCM) in Q2 2021, closing a stake of 128 shares — an estimated $11.5K sold.

RBA Wealth Management first reported a position in DXCM in Q1 2021 and held it in 1 quarter. The position peaked at $11.5K in Q1 2021. 726 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

RBA Wealth Management reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
RBA Wealth Management sold 128 DexCom shares in Q2 2021, an estimated $11.5K.
RBA Wealth Management first reported a position in DexCom in Q1 2021 and held it in 1 quarter.
RBA Wealth Management's DexCom position peaked at $11.5K in Q1 2021.
726 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on RBA Wealth Management's 13F filing for Q2 2021, filed 22 Jul 2021.